Geopolitics Alpha

Schedules of Controlled Substances: Placement of Centanafadine in Schedule III

Published . Updated .

GEOPOLITICS ALPHASchedules of ControlledSubstances: Placement ofCentanafadine in Schedule IIIDEAGEOPOLITICS ALPHA

Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. Please visit FederalRegister.gov API documentation or eCFR.gov API documentation to learn more about how to access

Directly affected

  • DEA Easterly Government Properties-6.3% 30d

    Named in this report.

Indirectly affected

  • XLRE Real Estate Select Sector SPDR+1.3% 30d

    Real Estate Select Sector SPDR holds the real estate sector that Easterly Government Properties belongs to, so it often moves with news about it.

  • WELL Welltower+0.2% 30d

    Welltower is a peer of Easterly Government Properties in real estate investment trusts; rivals often move on the same news.

  • PLD Prologis-5.8% 30d

    Prologis is a peer of Easterly Government Properties in real estate investment trusts; rivals often move on the same news.

  • EQIX Equinix

    Equinix is a peer of Easterly Government Properties in real estate investment trusts; rivals often move on the same news.

  • AMT American Tower+7.6% 30d

    American Tower is a peer of Easterly Government Properties in real estate investment trusts; rivals often move on the same news.

  • SPG Simon Property Group

    Simon Property Group is a peer of Easterly Government Properties in real estate investment trusts; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
DEANo price data for this ticker———————
XLRENo price data for this ticker———————
WELLNo price data for this ticker———————
PLDNo price data for this ticker———————
EQIXNo price data for this ticker———————
AMTNo price data for this ticker———————
SPGNo price data for this ticker———————

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

On July 24, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder in adults and pediatric patients aged 6 years…

Source: Federal Register

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

25 out of 100

“Schedules of Controlled Substances: Placement of Centanafadine in Schedule III” scores 25 out of 100. The score uses 2 sources.